Providing expert strategic advice

The Leadership Advisory Board of the Australian Regenerative Medicine Institute (ARMI) provides strategic guidance that strengthens the Institute’s reputation and impact. Comprising leaders from science, industry, philanthropy and public life, the Board works with the ARMI Executive to promote the Institute’s vision, achievements and role as a global centre for regenerative medicine. Through strong governance and informed decision‑making, the Board supports ARMI’s long‑term growth and success.

The Board helps advance ARMI’s goals by:

  • Offering strategic advice to the Director and the Executive, drawing on deep expertise and lived experience.
  • Supporting research excellence and translation by connecting ARMI with industry and innovation partners.
  • Strengthening philanthropic and donor relationships to advance ARMI’s fundraising objectives.
  • Enhancing advocacy and communications through active engagement with key stakeholders.

Peter Rogers AM (Chair)

Peter Rogers is Chair of Australian Regenerative Medicine Institute (ARMI) Board at Monash University. He is a member of Rotary’s Regional Board for South Pacific, and Emeritus Chairman of the Monash University Engineering and Information Technology Foundation. He is a former Councillor of the Graduate Union at University of Melbourne, former Chairman of the Australian Rotary Health District D9800 Committee and a past President of the Rotary Club of Melbourne.

Read more: Peter Rogers AM – Australian Regenerative Medicine Institute


Dr Meroula Richardson

Dr Meroula Richardson graduated in Medicine from the University of Western Australia and specialised in cardiology. Her interest in transplantation led to two years at Harefield Hospital (London, UK) training in cardiac transplantation under the guidance of Professor Sir Magdi Yacoub, a pioneer in the field. She returned to Australia in 1994 to an appointment as cardiologist with the Heart and Lung Replacement service at The Alfred Hospital (Melbourne) and in 1997 became a founding member of The Alfred’s Heart Failure Unit. On sabbatical leave in 2001, she returned to Harefield Hospital for training in the implantation of cardiac implantable electronic devices (pacemakers and defibrillators), specifically those capable of delivering cardiac resynchronisation therapy for selected patients with heart failure. Read more: Dr Meroula Richardson – Australian Regenerative Medicine Institute

Emeritus Professor Claude Bernard AM

Professor Bernard is internationally recognized for his leading research on the pathogenesis and regulation of autoimmune diseases, more specifically Multiple Sclerosis (MS). His discoveries have significantly enhanced our understanding of cellular and molecular mechanisms underlying the cause of MS, which have led to the development of novel therapies to treat MS. He has published over 300 journal articles, reviews, conference proceedings and book chapters.

Read more: Emeritus Professor Claude Bernard AM – Australian Regenerative Medicine Institute

Richard Dent OAM FAICD (Chair, Development & Engagement Committee)

Richard Dent has exercised leadership for a better world for more than 25 years. He has dedicated over two decades to for-purpose organisations, serving across multiple executive, CEO, governance, and board positions. His extensive career experience spans critical sectors such as child, family, disability, advocacy/policy agencies, peak bodies, and professional associations. Richard is committed to inclusion, equity, governance, strategy and leadership; skilfully intersecting these with business and social policy.

Read more: Richard Dent OAM FAICD (Chair) – Australian Regenerative Medicine Institute

Madeleine McManus OAM, FIEAust, CPEng, EngExec

Madeleine McManus OAM, FIEAust, CPEng, EngExec is CEO of the Centre for Professional Engineering Education & Centre for Pavement Engineering Education, Global Director of Robogals , Director Victorian Business Licensing Authority (BLA) – where she has oversight of the Victorian Professional Engineering Registration Scheme, and Co-Chair National Future Cities Taskforce. Madeleine’s influence extends into regulatory oversight as a Director of the Victorian Business Licensing Authority (BLA), where she is responsible for the Victorian Professional Engineering Registration Scheme. She also holds a leadership position as Co-Chair of the National Future Cities Taskforce. Madeleine has developed substantial networks and high-level experience across government, defence, infrastructure, construction, research, and high-tech sectors.

Read more: Madeleine McManus OAM, FIEAust, CPEng, EngExec – Australian Regenerative Medicine Institute

Dr Duncan Thomson (Chair, Industry Advisory Committee)

Dr Duncan Thomson consults in the regenerative medicine and animal health sectors and brings a pragmatic passion for translational commercialisation. He is an experienced executive with >25 years’ experience in animal health, healthcare and pharmaceutical industries, having worked in senior management, marketing and sales and roles often overseeing research projects in Europe, the US and Australia. His career began as a veterinarian in Sydney, in the largest practice in Sydney and has always been at the cutting edge of development. He then worked in the UK before completing an MBA in the UK.

Read more: Dr Duncan Thomson – Australian Regenerative Medicine Institute

Katerina Aleksoska

Katerina is an experienced public servant and has worked across investment, industry development and policy roles. Most recently, Katerina has worked in investment attraction at Invest Victoria and Breakthrough Victoria and has extensive experience in life science and energy investments and projects. At Invest Victoria, Katerina was Market Lead for investments from Japan and Korea across a range of target industries including life science, advanced manufacturing, cleantech and food and fibre. Katerina was also the project manager for the AU$500M Hydrogen Energy Supply Chain pilot project.

Read more: Katerina Aleksoska – Australian Regenerative Medicine Institute

Roger Flynn

Roger Flynn’s career has been in the development, manufacture and distribution of engineered products, based in Australia and for a period in the United States (US). Early in his career he led divisions of large corporations. In the second half of his career, he was CEO and a Director of 4 ASX listed companies over several decades with operations in Australia, 5 Asian countries, New Zealand, South Africa, the US and the United Kingdom. He was also a Chair or Non-Executive Director of a number of other ASX-listed companies. He is a Governor of The Florey a Director of the Trustee company responsible for the Cunningham Dax Collection Trust and its 16,000 mental health related artworks.

Read more: Roger Flynn – Australian Regenerative Medicine Institute

Dr Alison Greenway BSc (Hons) PhD, LLB, GAICD

Dr Alison Greenway BSc (Hons) PhD, LLB, GAICD is currently Associate Dean and Senior Director Enterprise and Partnerships at Monash University. As a business development and commercialisation executive, Dr Greenway has extensive experience leading biomedical and public health business development activities in universities and medical research institutes. Alison has also run a consultancy. Dr Greenway is current the Secretary and Public Officer on the board of BioMelbourne Network.

Read more: Dr Alison Greenway BSc (Hons) PhD, LLB, GAICD – Australian Regenerative Medicine Institute

Professor Peter Currie FAA IntFRSE (Director of Research)

Peter Currie received his PhD in Drosophila genetics from Syracuse University, New York, USA.  He undertook postdoctoral training in zebrafish development at the Imperial Cancer Research Fund (now Cancer Research UK) in London, UK.  He has worked as an independent laboratory head at the UK Medical Research Council Human Genetics Unit in Edinburgh, UK and the Victor Chang Cardiac Research Institute in Sydney, Australia where he headed a research programme focused on skeletal muscle development and regeneration.

Read more: Professor Peter Currie FAA IntFRSE – Australian Regenerative Medicine Institute

Dr Marguerite Evans-Galea AM

With a finger on the pulse of Australia’s STEM ecosystem, Dr Evans-Galea is an accomplished executive and board director change-making at the interface of industry, academia and government. In 2025, Dr Evans-Galea was appointed Deputy Director, Strategy and Planning and is part of ARMI’s Executive. She leads the development and implementation of the Institute’s strategy and vision to drive sustainability and growth, develop the Institute’s diverse research leaders and rising stars, and support ARMI’s mission: the discovery and innovation of regenerative medicine and advanced therapies.

Read more: Dr Marguerite Evans-Galea AM – Australian Regenerative Medicine Institute

Professor Edwina McGlinn (Deputy Director, Research Strategy and Impact)

Professor McGlinn is an EMBL Australia Partner Network Lab Group Leader, based at the Australian Regenerative Medicine Institute (ARMI), Monash University.

Completing her PhD in developmental and molecular biology (1999-2004) at the Institute for Molecular Bioscience UQ, Professor McGlinn’s thesis identified novel downstream effectors of Sonic hedgehog in the developing mouse limb. She then became a Postdoctoral Research Fellow at Harvard Medical School USA (2004-2010), elucidating genetic networks involved in patterning the vertebrate limb and axial skeleton

Professor McGlinn serves on Monash University’s Athena Swan Steering Group, comprising a diverse body of academic and professional staff based in Australia and Malaysia, working in close partnership with the University’s Staff Equity, Diversity and Inclusion team. In 2025, Monash University became the first Group of Eight university in Australia to gain Science in Australia Gender Equity (SAGE) Athena Swan Silver accreditation for advancing gender equity, diversity and inclusion.

Driving ARMI’s leadership portfolio for Research Excellence and Mentorship, Professor McGlinn also works closely with the ARMI Executive and Faculty leadership to ensure researchers can lead and excel.

Read more: Professor Edwina McGlinn – Australian Regenerative Medicine Institute

BACK TO Leadership